Literature DB >> 31632586

LncRNA PCAT6 increased cholangiocarcinoma cell proliferation and invasion via modulating miR-330-5p.

Yongjie Xin1,2, Xu He1,2, Wei Zhao2, Meixiao Zhan2, Yong Li2, Jing Xiao2, Ke He3,4,5, Ligong Lu1,2.   

Abstract

Long non-coding RNAs (lncRNAs) act important roles in several tumors including cholangiocarcinoma. However, the expression pattern and function of PCAT6 in intrahepatic cholangiocarcinoma remains unknown. In our research, we showed that the PCAT6 expression level was upregulated in intrahepatic cholangiocarcinoma cell lines. The expression of PCAT6 in intrahepatic cholangiocarcinoma tissues than that in noncancerous samples and the higer expression of PCAT6 was associated with advanced stage. Ectopic expression of PCAT6 induced cell proliferation and invasion in cholangiocarcinoma cell. Moreover, we demonstrated that PCAT6 interacts with miR-330-5p by directly targeting and PCAT6 overexpression inhibited the expression of miR-330-5p in the ICC-9810 cell. We also showed that the expression level of miR-330-5p in intrahepatic cholangiocarcinoma samples was downregulated compared to noncancerous tissues. Interesting, we proved that the miR-330-5p expression was negative correlated with PCAT6 expression in intrahepatic cholangiocarcinoma. Ectopic expression of miR-330-5p suppressed cell proliferation and invasion. Finally, we showed that PCAT6 induced cell proliferation and invasion by decreasing miR-330-5p in cholangiocarcinoma cell. Taken together, these data suggested that lncRNA PCAT6 was an oncogenic player in the development of intrahepatic cholangiocarcinoma. AJTR
Copyright © 2019.

Entities:  

Keywords:  Intrahepatic cholangiocarcinoma; PCAT6; miR-330-5p; oncogene

Year:  2019        PMID: 31632586      PMCID: PMC6789233     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  37 in total

1.  Long noncoding RNA PCAT6 inhibits colon cancer cell apoptosis by regulating anti-apoptotic protein ARC expression via EZH2.

Authors:  Weimei Huang; Geng Su; Xiaoxian Huang; Angru Zou; Jingfang Wu; Yunchu Yang; Yaru Zhu; Shumei Liang; Deyu Li; Feng Ma; Linlang Guo
Journal:  Cell Cycle       Date:  2018-12-30       Impact factor: 4.534

2.  Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells.

Authors:  Solange Tréhoux; Fatima Lahdaoui; Yannick Delpu; Florence Renaud; Emmanuelle Leteurtre; Jérôme Torrisani; Nicolas Jonckheere; Isabelle Van Seuningen
Journal:  Biochim Biophys Acta       Date:  2015-05-31

3.  Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis.

Authors:  P Chusorn; N Namwat; W Loilome; A Techasen; C Pairojkul; N Khuntikeo; A Dechakhamphu; C Talabnin; W Chan-On; C K Ong; B T Teh; P Yongvanit
Journal:  Tumour Biol       Date:  2013-02-17

4.  The lncRNA n340790 accelerates carcinogenesis of thyroid cancer by regulating miR-1254.

Authors:  Qinghuai Li; Wei Shen; Xiaoyu Li; Linlei Zhang; Xiao Jin
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

5.  LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.

Authors:  Xiaoming Wang; Xiubo Lu; Zushi Geng; Guoyu Yang; Yang Shi
Journal:  J Cell Biochem       Date:  2017-06-22       Impact factor: 4.429

Review 6.  Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma.

Authors:  Hiroaki Haga; Irene Yan; Kenji Takahashi; Joseph Wood; Tushar Patel
Journal:  Gene Expr       Date:  2014

7.  Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma.

Authors:  Shouli Wang; Jikai Yin; Tao Li; Lijuan Yuan; Dong Wang; Jiaxing He; Xilin Du; Jianguo Lu
Journal:  Oncol Rep       Date:  2014-12-02       Impact factor: 3.906

8.  MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.

Authors:  Bei-Bei Su; Shu-Wei Zhou; Cai-Bin Gan; Xiao-Ning Zhang
Journal:  J Surg Res       Date:  2016-03-19       Impact factor: 2.192

9.  Long non-coding RNA LOC554202 modulates chordoma cell proliferation and invasion by recruiting EZH2 and regulating miR-31 expression.

Authors:  Xianli Ma; Shengjin Qi; Zhenying Duan; Hongzhan Liao; Baohua Yang; Wenbo Wang; Jie Tan; Qinghua Li; Xuewei Xia
Journal:  Cell Prolif       Date:  2017-09-30       Impact factor: 6.831

10.  Knockdown of Long Noncoding RNA PCAT6 Inhibits Proliferation and Invasion in Lung Cancer Cells.

Authors:  Li Wan; Lin Zhang; Kai Fan; Zai-Xing Cheng; Quan-Chao Sun; Jian-Jun Wang
Journal:  Oncol Res       Date:  2016       Impact factor: 5.574

View more
  12 in total

1.  A Novel Pyroptosis-Associated Long Noncoding RNA Signature to Predict the Prognosis of Patients with Colorectal Cancer.

Authors:  Sijun Chen; Jianwei Zhu; Xiaofei Zhi
Journal:  Int J Gen Med       Date:  2021-09-27

2.  Suppression of circulating AP001429.1 long non-coding RNA in obese patients with breast cancer.

Authors:  Hani Choudhry; Mohammed A Hassan; Abdulrahman L Al-Malki; Kaltoom A Al-Sakkaf
Journal:  Oncol Lett       Date:  2021-05-03       Impact factor: 2.967

3.  LncRNA SNHG11 Promotes Proliferation, Migration, Apoptosis, and Autophagy by Regulating hsa-miR-184/AGO2 in HCC.

Authors:  Wei Huang; Feizhou Huang; Zhao Lei; Hongwu Luo
Journal:  Onco Targets Ther       Date:  2020-01-14       Impact factor: 4.147

4.  LncRNA PCAT6 regulates the progression of pituitary adenomas by regulating the miR-139-3p/BRD4 axis.

Authors:  Peng Zhao; Jianhua Cheng; Bin Li; Ding Nie; Hongyun Wang; Chuzhong Li; Songbai Gui; Yazhuo Zhang
Journal:  Cancer Cell Int       Date:  2021-01-06       Impact factor: 5.722

5.  Long Non-Coding RNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma via Modulating miR-326 and RhoA-ROCK Signaling Pathway.

Authors:  Jianfei Tu; Fazong Wu; Li Chen; Liyun Zheng; Yang Yang; Xihui Ying; Jingjing Song; Chunmiao Chen; Xianghua Hu; Zhongwei Zhao; Jiansong Ji
Journal:  Front Oncol       Date:  2021-01-21       Impact factor: 6.244

6.  Assessing the Regulatory Functions of LncRNA SNHG11 in Gastric Cancer Cell Proliferation and Migration.

Authors:  Danyi Zhao; Huawei Chen; Bing Wang
Journal:  Front Cell Dev Biol       Date:  2021-03-18

Review 7.  PCAT6 may be a new prognostic biomarker in various cancers: a meta-analysis and bioinformatics analysis.

Authors:  Song-Bo Shi; Qing-Hao Cheng; Shi-Yi Gong; Ting-Ting Lu; Shi-Fang Guo; Shao-Ming Song; Yu-Ping Yang; Qi Cui; Ke-Hu Yang; Yao-Wen Qian
Journal:  Cancer Cell Int       Date:  2021-07-12       Impact factor: 5.722

Review 8.  The Role of lncRNA PCAT6 in Cancers.

Authors:  Siying Wang; Zhenyao Chen; Jingyao Gu; Xin Chen; Zhaoxia Wang
Journal:  Front Oncol       Date:  2021-07-13       Impact factor: 6.244

9.  Long non‑coding RNA PCAT6 promotes the development of osteosarcoma by increasing MDM2 expression.

Authors:  Xiliang Guan; Yufen Xu; Jufen Zheng
Journal:  Oncol Rep       Date:  2020-10-16       Impact factor: 3.906

10.  m6 A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization.

Authors:  Chuandong Lang; Chi Yin; Kaiyuan Lin; Yue Li; Qing Yang; Zhengquan Wu; Hong Du; Dong Ren; Yuhu Dai; Xinsheng Peng
Journal:  Clin Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.